NorthWest Biotherapeutics Inc (NWBO)

[Evaluate]

I am also under the impression that Woodford might not have any additional knowledge about the details of the partial hold than all the rest of the shareholders.

The company has confirmed that the suspension related simply to the recruitment of new patients and was a temporary measure while regulatory information was submitted, in line with clinical protocols. The trial is continuing and we see nothing untoward in this development.

The "nothing untoward" statement IMO just relates to the "development" that recruitment of new patients was suspended and a temporary measure while regulatory info was submitted, in line with clinical protocols.
Nowhere in this statement does it imply that Woodford was provided any additional details about the clinical hold.
And your quote that the company never shed any light on the regulatory intervention further seems to confirm that Woodford had no additional details.
At this time, I think it could be inappropriate for NWBO to provide Woodford with details about the hold, but not inform all shareholders simultaneously.